{"DataElement":{"publicId":"5665792","version":"1","preferredName":"Clinical Study Urothelial Carcinoma Pathological Staging Stratification Urothelial Carcinoma Pathologic Stage Type","preferredDefinition":"Information related to classifying patients into strata as part of the randomization process and for purposes of data analysis by the pathologic staging type of a malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).","longName":"CLSTDY_UROCA_PATH_STG_STRAT_TP","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"5665268","version":"1","preferredName":"Clinical Study Urothelial Carcinoma Pathological Staging Stratification","preferredDefinition":"Information related to classifying patients into strata as part of the randomization process and for purposes of data analysis by the pathologic staging of a malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).","longName":"CLSTDY_UROCA_PATH_STG_STRAT","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2430995","version":"1","preferredName":"Study","preferredDefinition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical trial.","longName":"C15206","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05D7809E-DF10-22B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-18","modifiedBy":"ONEDATA","dateModified":"2005-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5665475","version":"1","preferredName":"Urothelial Carcinoma Pathological Staging Stratification","preferredDefinition":"A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis). It is frequently papillary.:An examination that is performed to determine the extent of the spread of cancer based on histopathologic examination of one or more pathology specimens.  Pathologic staging uses evidence acquired during the process of clinical staging, supplemented by histopathologic examination of surgical specimens.:The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","longName":"C4030:C28257:C25689","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathological Staging","conceptCode":"C28257","definition":"An examination that is performed to determine the extent of the spread of cancer based on histopathologic examination of one or more pathology specimens. Pathologic staging uses evidence acquired during the process of clinical staging, supplemented by histopathologic examination of surgical specimens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stratification","conceptCode":"C25689","definition":"The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48A764D7-2927-6EEA-E053-F662850AC872","latestVersionIndicator":"Yes","beginDate":"2017-02-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-02-16","modifiedBy":"ONEDATA","dateModified":"2017-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"48983D1C-6929-3201-E053-F662850AF96D","latestVersionIndicator":"Yes","beginDate":"2017-02-15","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-02-15","modifiedBy":"MORENOC","dateModified":"2017-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5665471","version":"1","preferredName":"Urothelial Carcinoma Pathologic Stage Type","preferredDefinition":"The type of pathologic stage grouping of a malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis)._Caused by or altered by or manifesting disease or pathology._Any distinct time period in a sequence of events.","longName":"UROTCA_PATH_STG_TP","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pT4N0 or NX/pTanyN1-3","valueDescription":"pT4 Stage Finding N0 Stage Finding Or NX Stage Finding Pathologic T Stage Any N1 Stage Finding To N3 Stage Finding","ValueMeaning":{"publicId":"5665473","version":"1","preferredName":"pT4 Stage Finding N0 Stage Finding Or NX Stage Finding Pathologic T Stage Any N1 Stage Finding To N3 Stage Finding","longName":"5665473","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT4 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT4 stage finding is defined as follows: cancer with tumor of any size with direct extension to chest wall or skin, but only as described in pT4 sub-categories, in accordance with TNM guidelines; for cervical cancer, pT4 stage finding is defined as follows: cancer invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). (from AJCC 7th Ed.): A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.: Caused by or altered by or manifesting disease or pathology.: One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).: One, some, every, or all without specification.: A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.: Used as a function word to indicate direction, purpose, or movement.: A general term that refers to a TNM finding of cancer metastases in","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT4 TNM Finding","conceptCode":"C48772","definition":"A pathologic primary tumor TNM finding. The definition of pT4 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT4 finding is defined as follows: cancer with tumor of any size with direct extension to chest wall or skin, but only as described in pT4 sub-categories, in accordance with TNM guidelines; for cervical cancer, pT4 finding is defined as follows: cancer invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"9"},{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"8"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Any","conceptCode":"C81168","definition":"One, some, every, or all without specification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"N1 TNM Finding","conceptCode":"C48706","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N3 TNM Finding","conceptCode":"C48714","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48A6B1BF-6A6C-2018-E053-F662850A8407","latestVersionIndicator":"Yes","beginDate":"2017-02-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-02-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"48A6B1BF-6A85-2018-E053-F662850A8407","beginDate":"2017-02-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-02-16","modifiedBy":"ONEDATA","dateModified":"2017-02-16","deletedIndicator":"No"},{"value":"pT2/3N0 or NX","valueDescription":"pT2 Stage Finding pT3 Stage Finding N0 Stage Finding Or NX Stage Finding","ValueMeaning":{"publicId":"5665474","version":"1","preferredName":"pT2 Stage Finding pT3 Stage Finding N0 Stage Finding Or NX Stage Finding","longName":"5665474","preferredDefinition":"A pathologic primary tumor TNM stage finding. The definition of pT2 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT2 stage finding is defined as follows: cancer with tumor size more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for colorectal cancer, pT2 stage finding is defined as follows: cancer with invasion into the muscularis propria. (from AJCC 6th and 7th Eds.): A pathologic primary tumor TNM stage finding.  The definition of pT3 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT3 stage finding is defined as follows: cancer with tumor size more than 5.0 cm in greatest dimension; for kidney cancer, pT3 stage finding is defined as follows: cancer with tumor extending into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. (from AJCC 7th Ed.): A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT2 TNM Finding","conceptCode":"C48764","definition":"A pathologic primary tumor TNM finding. The definition of pT2 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT2 finding is defined as follows: cancer with tumor size more than 2.0 cm, but not more than 5.0 cm in greatest dimension; for colorectal cancer, pT2 finding is defined as follows: cancer with invasion into the muscularis propria. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"pT3 TNM Finding","conceptCode":"C48768","definition":"A pathologic primary tumor TNM finding. The definition of pT3 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT3 finding is defined as follows: cancer with tumor size more than 5.0 cm in greatest dimension; for kidney cancer, pT3 finding is defined as follows: cancer with tumor extending into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond Gerota's fascia. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48A6B1BF-6A95-2018-E053-F662850A8407","latestVersionIndicator":"Yes","beginDate":"2017-02-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-02-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"48A6B1BF-6AAE-2018-E053-F662850A8407","beginDate":"2017-02-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-02-16","modifiedBy":"ONEDATA","dateModified":"2017-02-16","deletedIndicator":"No"},{"value":"pT-any N+ (any)","valueDescription":"pT0 Stage Finding To pT4 Stage Finding And Pathologic N1 Stage Finding To N3 Stage Finding","ValueMeaning":{"publicId":"6617372","version":"1","preferredName":"pT0 Stage Finding To pT4 Stage Finding And Pathologic N1 Stage Finding To N3 Stage Finding","longName":"6617372","preferredDefinition":"No morphologic evidence of primary tumor, in accordance with TNM classification system guidelines.: Used as a function word to indicate direction, purpose, or movement.: A pathologic primary tumor TNM stage finding.  The definition of pT4 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT4 stage finding is defined as follows: cancer with tumor of any size with direct extension to chest wall or skin, but only as described in pT4 sub-categories, in accordance with TNM guidelines; for cervical cancer, pT4 stage finding is defined as follows: cancer invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). (from AJCC 7th Ed.): An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Caused by or altered by or manifesting disease or pathology.: A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.: Used as a function word to indicate direction, purpose, or movement.: A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to m","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT0 TNM Finding","conceptCode":"C48758","definition":"No morphologic evidence of primary tumor, in accordance with TNM classification system guidelines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"pT4 TNM Finding","conceptCode":"C48772","definition":"A pathologic primary tumor TNM finding. The definition of pT4 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT4 finding is defined as follows: cancer with tumor of any size with direct extension to chest wall or skin, but only as described in pT4 sub-categories, in accordance with TNM guidelines; for cervical cancer, pT4 finding is defined as follows: cancer invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"N1 TNM Finding","conceptCode":"C48706","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N3 TNM Finding","conceptCode":"C48714","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7FAA7BBA-E496-69E1-E053-F662850ACA1A","latestVersionIndicator":"Yes","beginDate":"2019-01-17","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7FAA7BBA-E4AF-69E1-E053-F662850ACA1A","beginDate":"2019-01-17","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-17","modifiedBy":"ONEDATA","dateModified":"2019-01-17","deletedIndicator":"No"},{"value":"Positive invasive microscopic surgical margins (CIS at margins is considered negative margins)","valueDescription":"Positive Finding Invasive Microscopic Surgical Margin","ValueMeaning":{"publicId":"6608025","version":"1","preferredName":"Positive Finding Invasive Microscopic Surgical Margin","longName":"6608025","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.: Marked by a tendency to spread, especially into healthy surrounding tissue.: Too small to be seen except under a microscope.: One of the criteria for assessment of the effectiveness of given surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. It is defined by the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. There are four types of surgical margins: intracapsular or intralesional, marginal, wide, and radical.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Microscopic","conceptCode":"C25252","definition":"Too small to be seen except under a microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Surgical Margin","conceptCode":"C41227","definition":"One of the criteria for assessment of the effectiveness of given surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. It is defined by the tissue plane through which the dissection has been done and the actual or potential neoplastic tissue which has been left outside the boundary of a resected specimen within the patient. There are four types of surgical margins: intracapsular or intralesional, marginal, wide, and radical.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F20B261-76CF-7569-E053-F662850AFB9D","latestVersionIndicator":"Yes","beginDate":"2019-01-10","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-10","modifiedBy":"ONEDATA","dateModified":"2019-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F20B261-76E8-7569-E053-F662850AFB9D","beginDate":"2019-01-10","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-10","modifiedBy":"ONEDATA","dateModified":"2019-01-10","deletedIndicator":"No"},{"value":"pT4N0 or NX","valueDescription":"pT4 Stage Finding N0 Stage Finding Or NX Stage Finding","ValueMeaning":{"publicId":"7136652","version":"1","preferredName":"pT4 Stage Finding N0 Stage Finding Or NX Stage Finding","longName":"7136652","preferredDefinition":"A pathologic primary tumor TNM stage finding.  The definition of pT4 stage finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT4 stage finding is defined as follows: cancer with tumor of any size with direct extension to chest wall or skin, but only as described in pT4 sub-categories, in accordance with TNM guidelines; for cervical cancer, pT4 stage finding is defined as follows: cancer invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). (from AJCC 7th Ed.): A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pT4 TNM Finding","conceptCode":"C48772","definition":"A pathologic primary tumor TNM finding. The definition of pT4 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT4 finding is defined as follows: cancer with tumor of any size with direct extension to chest wall or skin, but only as described in pT4 sub-categories, in accordance with TNM guidelines; for cervical cancer, pT4 finding is defined as follows: cancer invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9C071455-4442-08BD-E053-F662850A2BCA","latestVersionIndicator":"Yes","beginDate":"2020-01-13","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-01-13","modifiedBy":"ONEDATA","dateModified":"2020-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9C071455-445B-08BD-E053-F662850A2BCA","beginDate":"2020-01-13","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-01-13","modifiedBy":"ONEDATA","dateModified":"2020-01-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5665470","version":"1","preferredName":"Urothelial Carcinoma Pathologic Stage Type","preferredDefinition":"A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis). It is frequently papillary.:Caused by or altered by or manifesting disease or pathology.:Any distinct time period in a sequence of events.:Something distinguishable as an identifiable class based on common qualities.","longName":"C4030:C25610:C48308:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage","conceptCode":"C48308","definition":"Any distinct time period in a sequence of events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"48A6B1BF-6A2F-2018-E053-F662850A8407","latestVersionIndicator":"Yes","beginDate":"2017-02-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-02-16","modifiedBy":"ONEDATA","dateModified":"2017-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"48A6B1BF-6A40-2018-E053-F662850A8407","latestVersionIndicator":"Yes","beginDate":"2017-02-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-02-16","modifiedBy":"MORENOC","dateModified":"2020-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic Stage","type":"Preferred Question Text","description":"Pathologic Stage","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"48A75406-FB62-2034-E053-F662850AB2F4","latestVersionIndicator":"Yes","beginDate":"2017-02-16","endDate":null,"createdBy":"MORENOC","dateCreated":"2017-02-16","modifiedBy":"MORENOC","dateModified":"2017-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}